Views & Analysis
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Health literacy for the intellectually disabled: is pharma doing enough?
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Patients and Partnerships, health literacy, Olivia Kersey, Patients and Partnerships, Prime Global
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Leveraging real-world data to meet payers’ needs
mike.hammerton@pharmaphorum.com
Certara, Deep Dive, Deep Dive: Patients and Partnerships, Lee Stern, Patients and Partnerships, real world data, Shawn Bates
0 Comment
Patients/ Views & Analysis/ Views and analysis
Time for change: PhRMA survey shows insurance creates barriers to healthcare in US
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Time for a new model in patient access
mike.hammerton@pharmaphorum.com
Astellas, Astellas Pharma Europe, Deep Dive, Deep Dive: Patients and Partnerships, Mig Sleeper, Patients and Partnerships
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Time to take patient engagement to the next level
mike.hammerton@pharmaphorum.com
Dawn Lobban, Deep Dive, Deep Dive: Patients and Partnerships, Envision Pharma, Patients and Partnerships, Sarah Avent
0 Comment
Patients/ Views & Analysis/ Views and analysis
UK-wide whole genome sequencing for newborns is feasible – but there are some key questions to answer first
mike.hammerton@pharmaphorum.com
AstraZeneca, COVID-19, EFPIA, healthcare, HTA, NICE, sustainable healthcare
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Patients want to be heard. Is pharma listening?
mike.hammerton@pharmaphorum.com
Axon, Deep Dive, Deep Dive: Patients and Partnerships, Natalie Turner, Patients and Partnerships
0 Comment
Deep Dive/ Patients/ Views & Analysis/ Views and analysis
Three views on technology improving clinical trial efficiency
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Patients and Partnerships, Marie Emms, Patients and Partnerships, syneos health
0 Comment